Actuate Therapeutics Inc
ACTU · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | |
|---|---|---|---|
| Revenue | $0 | $0 | $0 |
| % Growth | – | – | – |
| Cost of Goods Sold | $0 | $0 | $0 |
| Gross Profit | $0 | $0 | $0 |
| % Margin | – | – | – |
| R&D Expenses | $19 | $22 | $16 |
| G&A Expenses | $6 | $3 | $4 |
| SG&A Expenses | $6 | $3 | $4 |
| Sales & Mktg Exp. | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $0 |
| Operating Expenses | $25 | $25 | $20 |
| Operating Income | -$25 | -$25 | -$20 |
| % Margin | – | – | – |
| Other Income/Exp. Net | -$2 | $0 | $0 |
| Pre-Tax Income | -$27 | -$25 | -$20 |
| Tax Expense | $0 | $0 | $0 |
| Net Income | -$27 | -$25 | -$20 |
| % Margin | – | – | – |
| EPS | -3.26 | -1.65 | -1.34 |
| % Growth | -97.6% | -23.1% | – |
| EPS Diluted | -3.26 | -1.65 | -1.34 |
| Weighted Avg Shares Out | 20 | 15 | 15 |
| Weighted Avg Shares Out Dil | 20 | 15 | 15 |
| Supplemental Information | – | – | – |
| Interest Income | $0 | $0 | $0 |
| Interest Expense | -$0 | $0 | $0 |
| Depreciation & Amortization | $2 | $0 | $0 |
| EBITDA | -$25 | -$24 | -$20 |
| % Margin | – | – | – |